Skip to toolbar

Featured Research Sessions

Monday, July 27, 20208:30 AM – 9:30 AM    Microbiome in Alzheimer’s Disease: Pathogenesis and Treatment Implications  [SFRS1-02 Virtual Room Name: The Hague]  Speakers: Dr. Meiyu Geng, Sam Sisodia, Michael Heneka, Bruce Lamb                                                                                                             

Monday, July 27, 20208:30 AM – 8:55 AM    Functionalizing Genetic Variants in Alzheimer’s Disease  [SCR1-11 Virtual Room Name: Session Chatroom B]  Organizers: Greg Carter, Andy Saykin  Speakers:  Allison Goate, Karen Duff, Thomas Wingo, Mike Sasner  


Monday, July 27, 2020

  • Deep phenotyping of the 5XFAD model: IU/Jax/Pitt MODEL-AD Center [#45981]
  • Deep phenotyping of the 5XFAD model UCI [#36468]
  • Pharmacokinetic, Pharmacodynamics, and Transcriptomics Analysis of Verubecestat Treatment in 5XFAD mice [#41491]
  • Neurovascular Uncoupling of cerebral blood flow and glucose metabolism in APOE4, TREM2, and APOE4.TREM2 mice [#41531]
  • Hallmarks of Late-Onset Alzheimer’s Disease in a Humanized Mouse Model [#45162]
  • Transcriptomic Profiling of APOE4/Trem2*R47H Mouse Models for Late Onset Alzheimer’s Disease [#45390]
  • N-of-1-pathways transcriptomic analysis reveals distinct subtypes of Alzheimer’s Disease [#46575]
  • Natural genetic variation alters Alzheimer’s-related gene expression modules in mice
  • Translating genetic risk variants in disease-associated enhancers into novel mouse models of Alzheimer’s disease [#40529]
  • Lifespan neuroimaging of the 5XFAD mouse model of Alzheimer’s Disease:  Evolution of metabolic and vascular perturbations [#40548]
  • Lifespan diffusion MRI reveals regional abnormalities in the 5XFAD model of Alzheimer’s Disease [#43355]

Wednesday, July 29, 2020

  • The IUSM-Purdue Alzheimer’s Disease Drug Discovery Center: A member of the NIH-Funded TREAT-AD Consortium. [#41107]